S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 181 to 215 of 215

Issue Date	Title / Author(s) / Citation	File
2016-04	Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications Ock, Chan-Young; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.19 No.2, pp.421-430	DOI
2016-06	Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy? Park, H. J.; Kim, K.; Paik, J. H.; Chie, E. K.; Kim, S.; Jang, J. -Y.; Kim, S. W.; Han, S. -W.; Oh, D. -Y.; Im, S. -A.; Kim, T. -Y.; Bang, Y. -J.; Ha, S. W. Clinical and Translational Oncology, Vol.18 No.6, pp.625-631	DOI
2016-06	Prognostic role of body mass index in advanced small bowel adenocarcinoma patients receiving palliative chemotherapy Lee, Dae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Nutrition and Cancer, Vol.68 No.5, pp.750-755	DOI
2016-07	Src as a Therapeutic Target in Biliary Tract Cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.15 No.7, pp.1515-1524	DOI
2016-07	Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses Yang, Yaewon; Im, Seock-Ah; Keam, Bhumsuk; Lee, Kyung-Hun; Kim, Tae-Yong; Suh, Koung Jin; Ryu, Han Suk; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young BMC Cancer, Vol.16, p. 515	DOI
2016-07	Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer Cha, Yongjun; Kim, Kyung-Ju; Han, Sae-Won; Rhee, Ye Young; Bae, Jeong Mo; Wen, Xianyu; Cho, Nam-Yun; Lee, Dae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Kang, Gyeong Hoon; Kim, Tae-You British Journal of Cancer, Vol.115 No.2, pp.164-171	DOI
2016-07	Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX Kim, Mi-Jung; Han, Sae-Won; Lee, Dae-Won; Cha, Yongjun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Kim, Se Hyung; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Cancer Research and Treatment, Vol.48 No.3, pp.990-997	DOI
2016-07	Concurrent chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: A retrospective cohort study Choi, Younak; Oh, Do-Youn; Kim, Kyubo; Chie, Eui Kyu; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Ha, Sung Whan; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.3, pp.1045-1055	DOI
2016-08	Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. American Journal of Clinical Oncology, Vol.39 No.4, pp.346-349	DOI
2016-08	Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer Lee, Su Hyun; Ha, Seunggyun; An, Hyun Joon; Lee, Jae Sung; Han, Wonshik; Im, Seock-Ah; Ryu, Han Suk; Kim, Won Hwa; Chang, Jung Min; Cho, Nariya; Moon, Woo Kyung; Cheon, Gi Jeong European Journal of Nuclear Medicine and Molecular Imaging, Vol.43 No.9, pp.1574-1584	DOI
2016-09	Therapeutic implication of HER2 in advanced biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Cha, Yongjun; Ha, Hyerim; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Oncotarget, Vol.7 No.36, pp.58007-58021	DOI
2016-11	Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy Ha, Hyerim; Nam, Ah-Rong; Bang, Ju-Hee; Park, Ji-Eun; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Oncotarget, Vol.7 No.47, pp.76604-76612	DOI
2016-11	TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials Lee, Dae-Won; Jang, Myoung-Jin; Lee, Kyung-Hun; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You British Journal of Cancer, Vol.115 No.10, pp.1201-1205	DOI
2016-12	Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy Chang, Ji Hyun; Jeon, Wan; Kim, Kyubo; Shin, Kyung Hwan; Han, Wonshik; Noh, Dong-Young; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Journal of Breast Cancer, Vol.19 No.4, pp.394-401	DOI
2017-01	Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment An, Eunkyung; Ock, Chan Young; Kim, Tae You; Lee, Kyung Hun; Han, Se Won; Im, Seock Ah; Kim, Tae Yong; Liao, Wei Li; Cecchi, Fabiola; Blackler, Adele; Thyparambil, Sheeno; Kim, W. H.; Burrows, Jon; Hembrough, Todd; Catenacci, Daniel V.T.; Oh, Do Youn; Bang, Yung–Jue Annals of Oncology, Vol.28 No.1, pp.110-115	DOI
2017-01	Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.1, pp.164-174	DOI
2017-01	Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.2, pp.2329-2341	DOI
2017-03	Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Lee, Joongyub; Bang, Ju-Hee; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.2, pp.254-262	DOI
2017-04	Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea Beom, Seung Hoon; Oh, Jisu; Kim, Tae-Yong; Lee, Kyung-Hun; Yang, Yaewon; Suh, Koung Jin; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.2, pp.454-463	DOI
2017-04	Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer Hong, A. R.; Kim, J. H.; Lee, K. H.; Kim, T. Y.; Im, S. A.; Kim, T. Y.; Moon, H. G.; Han, W. S.; Noh, D. Y.; Kim, S. W.; Shin, C. S. Osteoporosis International, Vol.28 No.4, pp.1413-1422	DOI
2017-04	Phosphorylated Akt expression as a favorable prognostic factor for patients undergoing curative resection and adjuvant chemoradiotherapy for proximal extrahepatic bile duct cancer Kim, Byoung Hyuck; Kim, Kyubo; Min, Hye Sook; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Jang, Ja-June; Ha, Sung W. American Journal of Clinical Oncology, Vol.40 No.2, pp.158-162	DOI
2017-07	Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis Kim, Seongyeong; Min, Ahrum; Lee, Kyung-Hun; Yang, Yaewon; Kim, Tae-Yong; Lim, Jee Min; Park, So Jung; Nam, Hyun-Jin; Kim, Jung Eun; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae-You; Hangauer, David; Lau, Johnson Yiu-Nam; Im, Kyongok; Lee, Dong Soon; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.3, pp.643-655	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI
2017-10	Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate Lim, Yoojoo; Lim, Jee Min; Jeong, Won Jae; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Tae-Yong; Kim, Tae Min; Han, Sae-Won; Oh, Do Youn; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.4, pp.1033-1043	view file DOI
2017-10	Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79441-79452	DOI
2017-12	Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis Park, Jin Hyun; Im, Seock-Ah; Byun, Ja Min; Kim, Ki Hwan; Kim, Jin-Soo; Choi, In Sil; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do Youn; Kim, Tae-You Journal of Breast Cancer, Vol.20 No.4, pp.347-355	DOI
2018-03	A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma Lee, Dae-Won; Lee, Kyung-Hun; Kim, Hee-Jun; Kim, Tae-Yong; Kim, Jin-Soo; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You BMC Cancer, Vol.18 No.1, p. 252	DOI
2018-03	Integrated 18F-FDG PET/MRI in breast cancer: Early prediction of response to neoadjuvant chemotherapy Cho, Nariya; Im, Seock-Ah; Cheon, Gi Jeong; Park, In-Ae; Lee, Kyung-Hun; Kim, Tae-Yong; Kim, Young Seon; Kwon, Bo Ra; Lee, Jung Min; Suh, Hoon Young; Suh, Koung Jin European Journal of Nuclear Medicine and Molecular Imaging, Vol.45 No.3, pp.328-339	DOI
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2019-01	Landscape of actionable genetic alterations profiled from 1,071 tumor samples in Korean cancer patients Lee, Se-Hoon; Lee, Boram; Shim, Joon Ho; Lee, Kwang Woo; Yun, Jae Won; Kim, Sook-Young; Kim, Tae-You; Kim, Yeul Hong; Ko, Young Hyeh; Chung, Hyun Cheol; Yu, Chang Sik; Lee, Jeeyun; Rha, Sun Young; Kim, Tae Won; Jung, Kyung Hae; Im, Seock-Ah; Moon, Hyeong-Gon; Cho, Sukki; Kang, Jin Hyoung; Kim, Jihun; Kim, Sang Kyum; Ryu, Han Suk; Ha, Sang Yun; Kim, Jong Il; Chung, Yeun-Jun; Kim, Cheolmin; Kim, Hyung-Lae; Park, Woong-Yang; Noh, Dong-Young; Park, Keunchil Cancer Research and Treatment, Vol.51 No.1, pp.211-222	DOI
2019-12	Targeted next-generation DNA sequencing identifies Notch signaling pathway mutation as a predictor of radiation response Jeon, Seung Hyuck; Chie, Eui Kyu; Kim, Yi-Jun; Lee, Kyung-Hun; Lee, Hyun-Seob; Kim, Min Jung; Im, Seock-Ah; Kim, Jong-Il; Kim, Tae-You International Journal of Radiation Biology, Vol.95 No.12, pp.1640-1647	DOI
2020-04	Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor–Positive Early Breast Cancer Yoo, Shin Hye; Kim, Tae-Yong; Kim, Miso; Lee, Kyung-Hun; Lee, Eunshin; Lee, Han-Byoel; Moon, Hyeong-Gon; Han, Wonshik; Noh, Dong-Young; Han, Sae-Won; Kim, Tae-You; Im, Seock-Ah Clinical Breast Cancer, Vol.20 No.2, pp.98-107.e1	DOI
2020-04	Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS Park, Y. H.; Senkus-Konefka, E.; Im, S. -A.; Pentheroudakis, G.; Saji, S.; Gupta, S.; Iwata, H.; Mastura, M. Y.; Dent, R.; Lu, Y. -S.; Yin, Y.; Smruti, B. K.; Toyama, T.; Malwinder, S.; Lee, S. C.; Tseng, L. -M.; Kim, J. H.; Kim, T. -Y.; Suh, K. J.; Cardoso, F.; Yoshino, T.; Douillard, J. -Y. Annals of Oncology, Vol.31 No.4, pp.451-469	DOI
2020-10	Circulating Osteocalcin-Positive Cells as a Novel Diagnostic Biomarker for Bone Metastasis in Breast Cancer Patients Lee, Kyung-Hun; Lee, Kyoung Jin; Kim, Tae-Yong; Hutomo, Febby; Sun, Hyun Jin; Cheon, Gi Jeong; Park, Serk In; Cho, Sun Wook; Im, Seock-Ah Journal of Bone and Mineral Research, Vol.35 No.10, pp.1838-1849	DOI
2021-02	Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib Lee, Dae-Won; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Tae-Yong; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Kim, Tae-You; Lee, Youngeun; Kim, Haeryoung; Lee, Kyung-Hun Clinical Cancer Research, Vol.27 No.3, pp.713-718	DOI

1 2 3 4